The €9 Trillion Question

The global wellness economy was worth roughly $6.3 trillion in 2023 and is projected to reach around $9 trillion by 2028. Capital moving at that scale does two things simultaneously: it funds genuine clinical infrastructure, and it funds a great deal of expensively branded nothing.

Both are now visible on this coastline, frequently within a few hundred metres of each other, and they are deliberately difficult to distinguish from the street.

Why the Riviera specifically

Three things converge here. A concentration of wealthy residents who buy this category. Thermal water and a climate that supports year-round outdoor practice. And a hospitality sector already building for the same customer, which means spa infrastructure arrives attached to hotels and residences rather than as standalone clinical ventures.

That last point is the useful one for a reader trying to sort the field. A wellness offer attached to a hotel is a hospitality product with clinical vocabulary. That is not a criticism; it is frequently very good at what it is. It is simply not medicine, and the pricing sometimes implies otherwise.

What the serious buyer actually wants

Our research on this reader is consistent: they buy mechanism and evidence, and they distrust anything that feels like marketing. A fast-growing cohort of wealthy women in particular drives values-led, holistic spending, and that cohort asks harder questions than the market is used to answering.

This buyer will pay a great deal for a protocol and almost nothing for a promise. Most of the sector is still selling promises.

Sorting the real from the branded

• Is there a licensed physician, physically present, who is accountable for what happens? Not an adviser, not a visiting consultant, not a medical director in another country.
• Is there a published protocol, or a menu? A protocol says what happens in what order and why. A menu says what you can buy.
• What is the evidence base for the specific intervention, and will they discuss its limits? Anyone unwilling to name a limitation is selling.
• What happens to your data, who holds it, and what occurs if the business is sold?
• Is there a follow-up, or does the relationship end at the invoice?

The unglamorous part that outperforms all of it

Everything the longevity industry sells sits on top of a foundation that is free and boring: sleep, movement, sun exposure, what you eat, and whether you have people to see. This coastline is unusually good at four of those five, and moving here plausibly does more for a household’s health than any protocol they will be sold once they arrive.

The fifth, having people to see, is the one that takes eighteen months and no clinic can supply. It is also, on the evidence, the one that matters most.